The development of a financial toxicity patient‐reported outcome in cancer: The COST measure

Publisher： John Wiley & Sons Inc

E-ISSN： 1097-0142|120|20|3245-3253

ISSN： 0008-543x

Source： CANCER, Vol.120, Iss.20, 2014-10, pp. : 3245-3253

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Choosing a patient-reported outcome measure

By McClimans Leah  

Theoretical Medicine, Vol. 32, Iss. 1, 2011-02 ,pp. : 47-60

Springer Publishing Company

Access to resources Recommend Favorite

Outcome and patient-reported toxicity in localised prostate cancer treated with dose-escalated hypofractionated intensity-modulated radiotherapy

By  

Journal of Radiotherapy in Practice, Vol. 12, Iss. 4, 2013-04 ,pp. : 326-333

Cambridge University Press

Access to resources Recommend Favorite

Synthesis and summary of patient‐reported outcome measures to inform the development of a core outcome set in colorectal cancer surgery

By  

COLORECTAL DISEASE, Vol. 1462-8910, Iss. 11, 2015-11 ,pp. : O217-O229

John Wiley & Sons Inc

Access to resources Recommend Favorite

Synthesis and summary of patient‐reported outcome measures to inform the development of a core outcome set in colorectal cancer surgery

By  

COLORECTAL DISEASE, Vol. 17, Iss. 11, 2015-11 ,pp. : O217-O229

John Wiley & Sons Inc

Access to resources Recommend Favorite

OHIP‐TMDs: a patient‐reported outcome measure for temporomandibular disorders

By  

COMMUNITY DENTISTRY AND ORAL EPIDEMIOLOGY, Vol. 43, Iss. 5, 2015-10 ,pp. : 461-470

John Wiley & Sons Inc

Access to resources Recommend Favorite